RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
Last chance for young adults to get vaccinated against HPV for free Today sees the launch of the ‘Do not miss out’ campaign, which calls on young people to get the first dose of the vaccine against the human papillomavirus (HPV) as soon as possible.
RIVM to begin systematic measuring of ultrafine particles in 2023 In 2023, RIVM will take systematic measurements of ultrafine particles in the outside air for the first time. This is necessary because little is known at present about ultrafine particles and their potential health effects. Ultrafine particles must be measured with different equipment than that usually used for particulate matter.
Vaccination rate again drops slightly, HPV vaccination rate drops considerably The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.
One Health European Joint Programme (EJP) Expert Meeting On the 4th and 5th of June 2018, an expert meeting was held at RIVM to redefine and prioritise the topics for One Health research and integrative activities in Europe.